# K133647: EMV3.1 Pro Blood Glucose System and EMV3.1 Self Monitoring Blood Glucose System

- Pathway: 510(k) (Special)
- Applicant: Eps Bio Technology Corp.
- Decided: Feb 27, 2014 after 92 days
- Product code: NBW (System, Test, Blood Glucose, Over The Counter)
- Device class: 2
- Regulation: 21 CFR 862.1345
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
No later device cites it as a predicate yet.
0 of 1 device in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. FDA’s file for it is a 510(k) statement, which names no predicate.

## Indications for use
The EMV3.1 Pro Blood Glucose System is intended for the quantitative measurement of glucose in venous whole blood or frecsh capillary whole blood from fingertip. Testing is done outside the body (In Vitro diagnostic use). It is intended for multiple-patient use in professional healthcare settings as an aid to monitor the effectiveness of diabetes control. The system is only used with single-use lancing devices. The system is not to be used on neonates, nor for the diagnosis of, or screening flor diabetes mellitus. The system includes the speaking function but is not intended to be operated by visually impaired users. The system consists of the EM V3.l Pmo meter and the EMV3.l Pmo test strips. The EMV3.l Pro meter only is used with the EMV3.I Pmo test strips to quantitatively measure glucose in venous whole blood or fresh capillary whole blood from fingertip. The EMV3.I Glucose Control Solution For use with the EMV3.l Pro Blood Glucose System as aquality control check to verify the accuracy of blood glucose test results. The EMV3.l Self Monitoring Blood Glucose System is intended for the quantitative measurement of glucose in fresh capillary whole blood from fingertip, palm, or forearm. Testing is done outside the body (in Vitro diagnostic use). It is indicated for use at home (over the counter [OTC]) by a single patient with diabetes and should not be shared, as mnaid to monitor the effectiveness of diabetes control. The system includes the speaking function but is not intended to be operated by visually impaired users. The system is not to be used on neonates, nor for the diagnosis of, or screening for diabetes mellitus. Alternative site testing can be only used during steady-state blood glucose conditions. The system consists of the EMV3.I meter and the EM V3.l test strips. The EMV3.1 meter only is used with the EMV3.l test strips to quantitatively measure glucose in fresh capillary whole blood from fingertip, palm, or forearm. The EMV3.I Glucose Control Solution For use with EMV3.I Blood Glucose Self Monitoring System as a quality control check to verify the accuracy of blood glucose test results.

Source page: https://510kreport.com/device/K133647
Methodology: https://510kreport.com/methodology